Psychiatry

Medicine & Life Sciences

1. Schizophrenia 100%
2. Genes 39%
3. Methamphetamine 36%
4. Single Nucleotide Polymorphism 34%
5. Meta-Analysis 34%
6. Bipolar Disorder 32%
7. Major Depressive Disorder 28%
8. Psychotic Disorders 23%
9. Population 22%
10. Genome-Wide Association Study 21%
11. Antipsychotic Agents 20%
12. Systematic Reviews 19%
13. Haplotypes 16%
14. Placebos 16%
15. Randomized Controlled Trials 15%
16. Depression 10%
17. Alleles 10%
18. Japan 9%
19. Mood Disorders 9%
20. blonanserin 9%
21. Aripiprazole 9%
22. Brain 8%
23. Case-Control Studies 8%
24. Genotype 8%
25. Odds Ratio 8%
26. Memantine 7%
27. Sleep 7%
28. Brain-Derived Neurotrophic Factor 7%
29. Linkage Disequilibrium 7%
30. Confidence Intervals 7%
31. Therapeutics 6%
32. Fluvoxamine 6%
33. Safety 6%
34. Sleep Initiation and Maintenance Disorders 6%
35. Mental Disorders 6%
36. Risperidone 6%
37. Genome 6%
38. Alzheimer Disease 5%
39. Cognition 5%
40. Network Meta-Analysis 5%
41. Serotonin Uptake Inhibitors 5%
42. Antidepressive Agents 5%